Treosulfan Regimen Approved for Allo-HSCT Conditioning in AML/MDS
The FDA approved treosulfan (Grafapex; Medexus Pharma) plus fludarabine (Fludara; Bayer HealthCare Pharmaceuticals) as a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in adult and pediatric patients aged 1 year and …